HomeNews

News

  • Researchers discover breakthrough in delaying Alzheimer’s progression

    • June 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Latest data on Ublituximab Ph 2 study in MS patients announced at EAN

    • June 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Additional Cladribine data reinforces efficacy in RMS patients

    • June 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva discontinues Chronic Cluster Headache trial for Fremanezumab

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche announces long term disability data for Ocrevus in PPMS patients

    • June 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Biogen launches Aby App for Multiple Sclerosis patients

    • June 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Another Alzheimer’s drug by Lilly & AstraZeneca fails clinical trials

    • June 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Prophylactic Migraine drug Atogepant displays positive efficacy and safety results in Ph 2b/3 trials

    • June 13, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Bacteriophages might be a potential cause of Parkinson’s disease, research finds

    • June 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Alembic’s generic drug for Major Depressive Disorder

    • June 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more